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The Tight skin (Tsk) mouse is an important model of skin ﬁbrosis that occurs in systemic sclerosis. These mice
develop skin tethering and thickening associated with expression of a mutant ﬁbrillin-1 gene. We show that Tsk
ﬁbrillin-1 leads to marked alterations in elastic ﬁbers of the hypodermis of Tsk animals. In Tsk mice, a prominent
elastic ﬁber layer found normally at the interface between hypodermal muscle and connective tissue was absent
from an early age. The lack of elastic ﬁbers at the hypodermal muscle–connective tissue (M–CT) interface was
associated with a loss of staining for ﬁbulin-5 in the same region. These mice also formed disorganized elastic
ﬁbers throughout hypodermal connective tissue as they aged. The increased elastic ﬁbers in Tsk hypodermal
connective tissue was associated with increased ﬁbrillin-1 and ﬁbulin-2 matrices. These results suggest that Tsk
ﬁbrillin-1 causes skin tethering by altering matrix protein composition in Tsk hypodermal connective tissues. The
closely parallel alterations in elastogenesis associated with increased ﬁbulin-2 in hypodermal connective tissues
and decreased ﬁbulin-5 at the hypodermal M–CT interface suggest that these proteins mediate the effect of Tsk-
ﬁbrillin-1 on elastogenesis.
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The Tight skin (Tsk) mouse is a model for dermal fibrosis in
scleroderma (Bocchieri and Jimenez, 1990). The phenotype
of this mouse is one of tethering of the skin to the underlying
tissues, similar to tethering of skin seen in systemic sclerosis
patients (Green et al, 1976). Much of the investigation into
this model has centered on observed increases in dermal
collagen deposition (Jimenez et al, 1984, 1986). Studies into
the genetics of the Tsk mouse have shown that the tight skin
phenotype is caused by a mutation in fibrillin-1 (Siracusa
et al, 1996; Kielty et al, 1998; Saito et al, 1999). This dominant
mutant contains a large in-frame insertion into the middle of
the fibrillin-1 gene. Heterozygous mice develop tight skin;
homozygous mice die in utero. How this mutant Tsk fibrillin-1
leads to the Tsk phenotype has remained unclear.
Fibrillin-1 encodes a large protein (350 kDa) that po-
lymerizes to form an extracellular fibrillar network (Sakai
et al, 1986; Handford et al, 2000). It is frequently found in
association with elastin and is thought to form the structural
framework for elastic fibers (Kielty et al, 2002). Mutations in
fibrillin-1 cause Marfan syndrome in man and genetically
engineered, decreased fibrillin-1 in mice produces similar
phenotypic manifestations (Dietz et al, 1991; Pereira et al,
1997, 1999; Robinson and Godfrey, 2000). Marfan syn-
drome typically shows skeletal and vascular, but no dermal,
manifestations (Robinson and Godfrey, 2000). Vascular
complications of Marfan syndrome include aortic aneu-
rysms due to incompetence of the prominent elastic fiber
network in this vessel. Thus, the cause of Marfan syndrome
has been generally regarded as due to decreased functional
fibrillin-1 (Kielty and Shuttleworth, 1994).
In contrast to mice with Marfan-like disease, Tsk mice
show skeletal, pulmonary, and dermal, but no or minimal
vascular manifestations. Several studies have sought to
explain how the mutant Tsk fibrillin-1 leads to the charac-
teristic dermal changes without the vascular changes. Tsk
animals produce a large Tsk fibrillin-1 protein (450 kDa).
Early studies suggested that fibrillin-1 and Tsk fibrillin-1
form distinct homopolymers, the latter performing an al-
tered function, but not disrupting the function of wild-type
fibrillin-1 homopolymers (Kielty et al, 1998). Altered Tsk fi-
brillin-1 was speculated to cause fibrosis by altered binding
of growth factors such as TGF-b or to latent TGF-b binding
proteins (Kielty et al, 1998; Saito et al, 1999). Tsk fibrillin-1,
however, appears to co-polymerize with wild-type fibrillin,
forming a qualitatively altered matrix (Gayraud et al, 2000).
Thus, Gayraud et al (2000) suggested that Tsk-fibrillin-1
qualitatively alters fibrillin matrix, decreasing the level of
functional fibrillin matrix below a threshold, such that skel-
etal and pulmonary but not vascular phenotypes are man-
ifest. In addition, altered fibrillin-1 matrix was found more
susceptible to proteolysis, possibly affecting macromolec-
ular assembly and fibrosis. Although these studies have
provided a framework for understanding the problem with
Tsk fibrillin-1, they have not clarified the molecular mech-
anisms underlying the Tsk skin phenotype.
Although increased dermal thickness resulting from in-
creased collagen deposition has been the most intensivelyAbbreviation: Tsk, Tight skin mouse
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studied in dermal pathology in Tsk animals, this pathology is
not apparent histologically in young (3 wk old) animals,
whereas the phenotype of tethered skin is present at birth.
Instead, the earliest description of the Tsk phenotype noted
the hypodermis as a site of particular pathology (Green et al,
1976). The hypodermis in Tsk animals is thicker and has
increased elastic fibers. Its location between the dermis and
underlying muscle is a logical site for pathology to lead to
skin tethering. These several observations suggest that ab-
normal fibrillogenesis of matrix proteins in the hypodermis
might cause the tethering of skin seen in these animals.
We have recently observed that the Tsk mice show in-
creased microfibril-associated protein-2 (MAGP-2) deposi-
tion in the dermis and hypodermis (Lemaire et al, 2004). Cell
lines conditionally expressing Tsk fibrillin-1 also showed in-
creased MAGP-2 matrix. Since MAGP-2 binds fibrillin-1,
these results indicate that Tsk fibrillin-1 alters binding of
fibrillin-1 matrix to at least one fibrillin-associated protein.
We have proposed that such altered binding to fibrillin-as-
sociated protein(s) could mediate the effect of Tsk fibrillin-1
on the skin.
Recent observations suggest that fibulins, another family
of extracellular matrix proteins, might mediate an effect of
Tsk fibrillin-1 on elastic fiber formation (reviewed in Kielty
et al, 2002). In many cases fibulins co-localize with fibrillins.
Fibulin-2 binds to the amino-terminus of fibrillin-1 (Reinhardt
et al, 1996). Several studies have implicated fibulins in
forming elastic fibers. Fibulin-1, fibulin-2, and fibulin-5 bind
tropoelastin (Sasaki et al, 1999; Yanagisawa et al, 2002).
The importance of fibulin-5 in elastic fiber formation has
been shown in mice deleted of this gene. These mice show
a diffuse loss of elastic fibers, and marked loss of skin
elasticity (Nakamura et al, 2002; Yanagisawa et al, 2002).
We have further characterized the abnormalities in elastic
fibers in the hypodermis of Tsk mice. We found that Tsk
fibrillin-1 disrupts a strip of elastic fibers that normally forms
at the interface between skeletal muscle and connective
tissue layers within the hypodermis. In addition, as Tsk mice
age, elastic fibers formed an irregular array within the con-
nective tissue layer of the hypodermis, an area that is de-
void of elastic fibers in control mice at all ages. These
differences in the distribution of elastic fibers in Tsk mice
were associated with a loss of fibulin-5 matrix at the hypo-
dermal muscle–connective tissue (M–CT) interface, and a
marked increase in fibrillin-1 and fibulin-2 matrices diffusely
in the hypodermis. These results suggest that Tsk fibrillin-1
alters the association of fibulin-2 and fibulin-5 with fibrillin-1
matrix and that these interactions may be important in reg-
ulating elastogenesis.
Results
Disorganization of elastic ﬁbers in the hypodermis of
Tsk mice In order to better understand the impact of mu-
tant Tsk fibrillin-1 on elastic fibers in the skin and underlying
connective tissues, the dermis and hypodermis of Tsk and
control littermate mice were dissected, fixed and stained
using Harts resorcin–fuchsin, a stain directed to elastic fib-
ers. To increase the sensitivity of this stain for elastic fibers,
the sections were not counterstained. Striking changes
were noted in the elastic fiber network of the hypodermis of
Tsk animals. In control mice, elastic fibers stained intensely
in a linear array between the layer of muscle located within
the hypodermis (hypodermal muscle) and a layer of con-
nective tissue (hypodermal connective tissue or superficial
fascia) between this muscular layer and the muscle of the
thoracic wall (Fig 1A, panel a). Remarkably, in the hypo-
dermis no elastic fibers were detectable outside of this
sharply demarcated region. In adult (3 mo old) Tsk animals
this linear array of elastic fibers was almost completely dis-
rupted (Fig 1A, panel b). Instead of the highly regular and
well-defined staining at the M–CT interface, elastic fibers
were stained in an irregular array reaching deep into and
within the hypodermal connective tissue. Staining of these
fibers was much less intense than the fibers at the M–CT
interface in control animals (cf. Fig 1, panels a and b).
Similar elastic fiber staining at the M–CT interface of the
hypodermis was seen in control mice at younger ages, in-
cluding 20-d and 6-wk-old mice (Fig 1A, panels c and e). As
in adult animals, elastic fibers were not found in hypodermal
connective tissues in control animals. The most remarkable
finding in young Tsk animals was a nearly complete loss of
staining at the M–CT interface of the hypodermis (Fig 1A,
panels d and f ). On careful examination, short fibers could
be found in the connective tissue hypodermis of the 20-d
Tsk mice (Fig 1A, panel d) and more developed elastic fibers
stained in the hypodermal connective tissue of 6-wk-old Tsk
mice (Fig 1A, panel f ).
To confirm the alterations in elastic fiber staining, hypo-
dermal tissues were stained by immunohistochemistry us-
ing an antibody to elastin. As expected based on the
chemical elastic fiber stain, elastin was stained intensely in
control mice at the M–CT interface in both 20-d and 6-wk-
old mice (Fig 1B, panels a and c). No staining over back-
ground was detected in the hypodermis of control animals.
Staining of elastin in 20-d and 6-wk-old Tsk animals re-
vealed a remarkable lack of elastin staining at the hypo-
dermal M–CT interface. Instead, occasional linear elastin
staining consistent with elastic fibers was detected in the
hypodermal connective tissue of Tsk animals at 6 wk, but
not 20 d of age (Fig 1B, panels b and d). Therefore, the
pattern of elastin staining by immunohistochemistry (Fig 1B)
is the same as that seen by chemical staining of elastic
fibers (Fig 1A), indicating profound alterations in elastin
deposition occur in the hypodermis of Tsk mice.
Increased ﬁbrillin matrix in the hypodermis of Tsk
mice Since fibrillin-1 is mutated in Tsk mice and forms
the structural framework for elastin deposition, it seemed
likely that the alterations in elastic fibers in Tsk animals
would be the result of altered fibrillin deposition. We have
previously noted subtle changes in fibrillin-1 staining of the
dermis of Tsk mice (Lemaire et al, 2004). Staining of the
hypodermal tissues, however, revealed much more striking
differences in Tsk compared with control mice.
Control mice showed light staining for fibrillin-1 through-
out hypodermal connective tissues (Fig 1C, panels a and c).
In contrast to staining for elastin in control mice, fibrillin-1
was not detected at an increased level at the hypodermal
M–CT interface. Tsk mice showed dramatically increased
fibrilllin-1 staining diffusely in hypodermal connective
tissues starting as early as 20 d of age (Fig 1C, panels b
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and d compared with panels a and c). Thus, although fibril-
lin-1 staining was not enhanced at the M–CT interface, it
was markedly increased in Tsk mice in a distribution that
was similar to that seen in control mice.
Altered ﬁbulin-2 and ﬁbulin-5 matrices in the hypoderm-
is of Tsk mice Since fibulin-2 and fibulin-5 have been im-
plicated in forming elastic fibers and fibulin-2 binds to
fibrillin-1, we studied the expression of these two proteins in
Tsk and control hypodermis. Control mice showed fibulin-2
and fibulin-5 staining at the hypodermal M–CT interface
(respectively, Fig 2A, panel a and Fig 2B, panel a). Hair fol-
licles in the dermis also stained lightly for fibulin-2 (Fig 2A,
panel c), but not fibulin-5 (data not shown). Fibulin-2 stain-
ing in Tsk mice was markedly increased throughout the
hypodermal connective tissue, such that enhanced expres-
sion at the M–CT interface seen in control mice could no
longer be distinguished (Fig 2A, panel b). Fibulin-2 expres-
sion was also increased around hair follicles (Fig 2A, panel
d ). In contrast, fibulin-5 expression was easily detected at
the M–CT interface in control skin, but was completely ab-
sent in Tsk skin (Fig 2B cf. panels a and b). Unlike fibulin-2,
this was not associated with an increase of fibulin-5 ex-
pression in the hypodermal connective tissue (Fig 2B, panel
b) or in hair follicles or dermis (data not shown).
Altered ﬁbulin-2 and ﬁbulin-5 matrices by Tsk ﬁbro-
blasts To characterize the effect of Tsk fibillin-1 in vitro,
cultured fibroblasts from neonatal Tsk and control mice
were stained for fibulin-2 and fibulin-5 matrices. Tsk fibro-
blasts produced more fibulin-2 matrix compared with con-
trol fibroblasts, with qualitative prominence of the matrix
fibers (compare Fig 2C, panels a and b). In contrast, Tsk
fibroblasts assembled markedly less fibulin-5 matrix com-
pared with control fibroblasts (Fig 2C, cf. panels c and d ).
Increased ﬁbulin-2 mRNA in skin of Tsk mice The
marked alterations in fibulin-2 and fibulin-5 staining in Tsk
skin suggested altered fibulin-2 and fibulin-5 synthesis or
degradation. We have previously noted marked increases in
MAGP-2 mRNA in Tsk skin (Lemaire1). To assess whether
increased fibulin-2 matrix and decreased fibulin-5 matrix
were due to changes in gene expression, Tsk and control
skin were analyzed for fibulin-2, fibulin-5, and fibrillin-1
mRNA expression. Fibulin-2 mRNA expression in Tsk skin
was increased 2–4-fold over expression in control skin
(Fig 3). The same cultures showed no change in fibulin-5
expression (Fig 3). Fibrillin-1 mRNA expression showed
Figure1
Elastic fiber and fibrillin-1 staining in Tight skin (Tsk) mice. Panel A.
Control (a, c, and e) and Tsk (b, d, and f ) mice skin sections were
stained with Harts resorcin–fuchsin elastin stain. Panels a and b are
from adult (3 mo old) animals; panels c and d are from 20-d-old an-
imals; and panels e and f are from 6-wk-old animals. Arrows indicate
elastic fibers. Panel B. Control (a and c) and Tsk (b and d) mice skin
sections were stained for elastin by immunohistochemistry. Panels a
and b are from 20-d-old animals and panels c and d are from 6-wk-old
animals. Positive staining is red and marked with arrows. Background
staining of areas of the slide exposed during tissue processing are
marked with stars and were stained similarly in control sections using
normal rabbit serum. Hypodermal connective tissue (HD), hypodermal
muscle (M) and deep dermal fatty connective tissue (F) are indicated.
Panel C. Control (a and c) and Tsk (b and d ) mice skin sections were
stained for fibrillin-1 by immunohistochemistry. Panels a and b are from
20-d-old animals and panels c and d are from 6-wk-old animals. Pos-
itive staining is red; counterstained nuclei are pale blue. Hypodermal
connective tissue (HD) and hypodermal muscle (M) are indicated.
1Lemaire, R: MAGP-2 increases type 1 collagen: Novel
mechanistic insights into extracellular matrix homeostasis (work
in progress).
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equimolar expression of wild-type and mutant fibrillin-1 in
Tsk mice. The sum of the levels of expression of these two
transcripts by Tsk mice was similar to the level of expression
of wild-type fibrillin-1 mRNA expression by control mice at
ages 1 and 4 wk (Fig 3). At 5 wk of age the sum of the levels
of fibrillin-1 transcripts in Tsk mice was slightly higher than
the level of expression of wild-type fibrillin-1 mRNA expres-
sion by control mice (Fig 3). This difference, however, did
not reach statistical significance (data not shown).
Discussion
Our results show that mutant Tsk fibrillin-1 causes a striking
change in hypodermal connective tissues matrices. These
changes are associated with skin tethering in these ani-
mals—the phenotype for which they were first described—
and point to several important insights into elastogenesis.
Skin tethering is due to adhesion of the dermis to the
underlying muscle. The hypodermis, which lies between
these two layers is a reasonable site for pathology leading
to such a phenotype and indeed increased elastic fibers in
this layer were noted in the original description of these
mice (Green et al, 1976). Our results are entirely consistent
with these earlier observations. Hypodermal elastic fibers in
Tsk mice, however, cannot be detected before 20 d after
birth in contrast to skin tethering, which can be detected at
birth (R. Lafyatis, unpublished observation), suggesting that
the alterations in elastic fibers do not cause skin tethering.
We have recently noted high levels of the fibrillin-1-associ-
ated protein MAGP-2 in the hypodermis, as well as in the
dermis of Tsk animals (Lemaire et al, 2004). Although
MAGP-2 might mediate skin tethering, its very small size
and close association with fibrillin-1 suggests that its role in
the skin might be primarily to support fibrillin-1 function.
Here we show that fibrillin-1 and fibulin-2 are also increased
in Tsk hypodermis. Potentially either of these proteins could
be directly responsible for skin tethering or might act
through as yet unidentified proteins.
Regardless of the specific protein(s) causing tethering,
our results strongly suggest that altered connective tissues
in the hypodermis, and not the dermis, cause this pheno-
type. Matrix alterations in the dermis, particularly in young
mice, are subtle and difficult to discern at the level of elastic
fibers and fibrillin-1 matrix (Lemaire et al, 2004). In contrast,
marked changes are seen in the hypodermis. Why the hy-
podermis shows more dramatic changes than the dermis is
uncertain, but it may be related to the relatively high pro-
portion of fibrillin-1 matrix found in this layer even in control
mice. Mutant Tsk fibrillin-1 dramatically enhances deposi-
tion of fibrillin-1 matrix, possibly accounting for the marked
alterations in hypodermis compared to dermis. How Tsk fi-
brillin-1 upregulates fibrillin-1 matrix in this region remains
unclear. The effect does not appear to be transcriptional, as
wild-type fibrillin-1 mRNA expression is equimolar to Tsk
fibrillin-1 mRNA expression, and fibrillin-1 and Tsk fibrillin-1
Figure2
Fibulin-2 and fibulin-5 staining in Tight skin (Tsk) mice and cultured
fibroblasts. Panel A. Control (a and c) and Tsk (b and d ) mouse skin
sections from 6-wk-old mice were stained in parallel for fibulin-2 by
immunohistochemistry. Positive staining is red and indicated by arrows
in panel a at the M–CT interface and in panel d around hair follicles;
positive staining is also prominent in the hypodermal connective tissue
region (HD) in panel b. Counterstained nuclei are pale blue. Hypodermal
connective tissue (HD), hypodermal muscle (M) and dermal hair follicles
(F) are indicated. Panel B. Control (a) and Tsk (b) mouse skin sec-
tions from 6-wk-old mice were stained in parallel for fibulin-5 by
immunohistochemistry. Positive staining is red and indicated by arrows
at the M–CT interface in (a); counterstained nuclei are pale blue. Hy-
podermal connective tissue (HD) and hypodermal muscle (M) are in-
dicated. Original magnification¼  400. Panel C. Neonatal dermal
fibroblasts from control (panels a and c) and Tsk (panels b and d) mice
were stained in parallel by immunocytochemistry for fibulin-2 (panels a
and b) or fibulin-5 (panels b and d ). Rhodamine-conjugated secondary
antibody is detected as red staining; nuclei were counterstained using
Hoescht dye and detected using UV light. Photographs of identical
regions of rhodamine and Hoescht staining were overlayed using
Adobe Photoshop (Photoshop, Adobe, San Jose, California). Original
magnification¼  400.
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mRNA expression together in Tsk mice represent that of
total fibrillin-1 mRNA expression in control mice. We pos-
tulate that Tsk fibrillin-1 stabilizes fibrillin-1 matrix in the
hypodermis, protecting it from degradation. The expression
of other matrix genes may also affect fibrillin fibrillogenesis
and/or degradation. Although Tsk fibrillin-1 does not affect
expression of its own mRNA, it dramatically affects expres-
sion of MAGP-2 (Lemaire2) and modestly affects expression
of fibulin-2 (shown above). These proteins might stabilize
fibrillin-1 matrix assembly or protect against degradation.
We cannot exclude the possibility that increased fibrillin-1
staining in the hypodermis is because Tsk fibrillin-1-induced
changes in fibrillin structure enhance accessibility of the
anti-fibrillin-1 antibody to the fibrillin matrix. The polyclonal
nature of this antibody and the associated increases in
fibulin-2 and MAGP-2 matrices, however, support the ob-
served increase in deposited fibrillin-1 protein. We did not
detect changes in fibulin-5 mRNA in skin, although changes
in local levels at the hypodermal M–CT junction might be
difficult to appreciate if mRNA expression is unaltered in
the remaining dermis. If Tsk fibrillin-1 inhibits fibulin-5 from
interacting with fibrillin-1, however, decreased fibulin-5
fibrillogenesis might lead to increased turnover of the free
fibulin-5 protein.
Two effects on elastogenesis are clearly observed in Tsk
hypodermis: loss of prominent elastic fibers at the hypo-
dermal M–CT interface, and the appearance at a later time
of disorganized elastic fibers within hypodermal connec-
tive tissue. Loss of elastic fibers at the hypodermal M–CT
junction occurs despite an overall increase in fibrillin-1
throughout the hypodermal connective tissue. One possible
explanation for this observation is that fibrillin-1 plays a
permissive, but not sufficient role in elastogenesis. Alterna-
tively, the altered fibrillin structure caused by Tsk fibrillin-1
expression may by itself inhibit elastastogenesis at the M–
CT junction. Loss of elastic fibers at the hypodermal M–CT
junction is also associated with a nearly complete loss of
prominent fibulin-5 staining in this layer. Thus, these results
are consistent with and support the key role of fibulin-5 in
elastogenesis shown by fibulin-5 deleted mice (Nakamura
et al, 2002; Yanagisawa et al, 2002). The phenotype in fib-
ulin-5 deleted mice is quite distinct, however, and in the skin
characterized by skin laxity. Our observations suggest that
loss of elastic fibers at the hypodermal M–CT interface
contribute to skin laxity in fibulin-5 deleted mice. We have
not seen alterations in elastic fibers in the dermis, nor do
these animals develop aortic abnormalities as described in
fibulin-5 deleted mice. Again, the early pathology in these
animals appears focussed in the hypodermis.
Consistent with the loss of fibulin-5 staining in the hypo-
dermal M–CT interface, cultured fibroblasts from Tsk mice
showed sparse fibulin-5 matrix, suggesting that Tsk fibrillin-
1 alters binding between fibulin-5 and fibrillin-1. Indeed, al-
though these two proteins have not been shown to interact
directly, fibrillin-1 is known to bind fibulin-2 (Reinhardt et al,
1996a). The entire fibulin-5 protein (448 amino acids) is
highly homologous to the carboxyterminus of fibulin-2 (1221
amino acids) with 28% identities (by Blast 2.2.6 search),
suggesting that this protein may also interact with fibrillin-1.
Our data suggest that Tsk fibrillin-1 might inhibit such an
interaction, either directly or indirectly.
Increased fibrillin-1 and fibulin-2 matrices accompany
the disorganized increase in elastic fibers in the connective
tissue hypodermis of adult Tsk mice. Since these two
proteins are known to interact physically and co-localize
(Reinhardt et al, 1996a; Raghunath et al, 1999), we postu-
late that fibulin-2 increases as a result of increased fibrillin-1
matrix. Our immunfluorescent results suggest that fibulin-2
may also bind with higher affinity to fibrillin-1 matrix con-
taining Tsk fibrillin-1; however, more quantitative assays
would be required to clearly answer this question.
Since we cannot detect fibulin-5 in the hypodermis, our
data suggest that other microfibril-associated protein(s)
might mediate or contribute to increased elastogenesis in
Tsk hypodermis. Fibulin-2 is known to bind with high affinity
to elastin in addition to fibrillin-1, providing one candidate
for mediating altered Tsk hypodermal elastogenesis. Alter-
natively, MAGP-2, another fibrillin-associated protein up-
regulated in Tsk hypodermis, might potentially stimulate
hypodermal elastogenesis. Neither fibulin-2 nor MAGP-2,
however, has yet been shown to regulate elastogenesis.
Possibly other microfibril-associated proteins might
Figure 3
Fibulin-2 and fibulin-5 mRNA expression by Tight skin (Tsk) mice. Panels A and B. RNA from skin of Tsk and control (WT) mice at 1 and 4 wk
(panel A) and 5 wk (panel B) of age were purified and analyzed for fibrillin-1, fibulin-2, and fibulin-5 mRNA expression by serial hybridization of
blotted RNA. Control staining of 28S rRNA is show at the bottom. Panel C. Graphical presentation of fibulin-2 and fibulin-5 hybridization signals
quantified using supplied phosphorimaging software, normalized to 28S rRNA staining and then renormalized to WT mRNA expression. Error bars
indicate standard deviations. Combining data in the first experiment from 1 and 4 wk of age, fibulin-2 expression is statistically significant if WT data
is used to control for both Tsk samples at week 4 (po0.05, Student’s two-tailed, paired t test). In the second experiment, the difference between Tsk
compared to WT fibulin-2 expression at 5 weeks is statistically significant (po0.05, Student’s two-tailed, unpaired t test).
2Lemaire, R (work in progress).
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mediate the effect of Tsk fibrillin-1 on hypodermal elasto-
genesis, such as MAGP-1, latent TGF-b-binding proteins
(LTBP), microfibril-associated proteins (MFAP), emilins, fib-
ulins 1, 3, or 4, decorin, versican or others (reviewed in
Kielty et al, 2002). In contrast to MAGP-2, we have found no
change in MAGP-1 expression in Tsk skin (unpublished ob-
servations), and we are currently investigating LTBP. Per-
haps most intriguing is emilin-1, since its deletion results in
altered elastogenesis, and it binds to both fibulin-5 and el-
astin (Zanetti et al, 2004). These or other unidentified matrix
protein might mediate the effect of Tsk fibrillin-1 on hypo-
dermal elastogenesis.
Increased transcription of fibulin-2 (shown here) and
MAGP-2 (manuscript in preparation) in Tsk skin suggests
that increased fibrillin-1, fibulin-2, and/or MAGP-2 matrices
might transmit a signal into fibroblasts. Fibrillin-1, fibulin-2,
and MAGP-2 all contain RGD motifs and bind to integrin
receptors (Pfaff et al, 1995, 1996; Sakamoto et al, 1996;
D’Arrigo et al, 1998). Possibly alterations in these matrices
signal fibroblasts through integrins. Fibrillin-1 also contains
seven latent TGF-b binding motifs, none of which have been
shown to interact directly with latent TGF-b, and a binding
site for latent TGP protein 1 (Gleizes et al, 1996; Reinhardt
et al, 1996b; Isogai et al, 2003). Possibly, altered binding or
activation of TGF-b by Tsk fibrillin-1 on fibrillin binding to
LTBP-1 might mediate increased fibulin-2 and MAGP-2
transcription. Integrin or TGF-b might contribute to a coor-
dinated regulation of elastic fiber protein gene expression
during normal development. Potentially, dysregulation of
such processes might contribute to the altered matrices in
Tsk hypodermis.
In summary, we show that Tsk mice have marked chang-
es in fibulin-2 and fibulin-5 matrices in hypodermal tissues.
These changes parallel changes in elastogenesis and sug-
gest that Tsk fibrillin-1 might cause skin tethering by in-
creased hypodermal deposition and increased binding of
fibrillin-1 matrix to fibulin-2. Our results are consistent with
recent observations implicating fibulins in elastogenesis,
and in particular suggest that fibulin-2 might play a redun-
dant role with fibulin-5 in elastic fiber formation.
Materials and Methods
Mice Tsk B6Fbntsk/þ mice were bred within the Boston University
Animal Facility according to an approved Institutional Animal Care
and Use Committee protocol. Mice were bred to homozygous
pallid B6Pldnpa/pa mice. The closely linked pallid coat color gene
is thus held in trans to the Tsk gene in heterozygous Tsk mice.
B6Fbntsk/þ mice were easily identified by black coat color, com-
pared with the pallid coat color in non-Tsk mice; the phenotype
was confirmed by increased skin tethering in Tsk mice.
Antibodies Antibody to elastin were purchased from Elastin Prod-
ucts (Owensville, Missouri). Dr Lynn Sakai kindly provided rabbit anti-
serum to fibrillin-1 (pAb9543 (Reinhardt et al, 1996a)). Polyclonal
rabbit antibodies to fibulin-2 have been described previously
(Miosge et al, 1996). Polyclonal antibodies to fibulin-5 were prepared
by immunizing rabbits with Keyhole limpet hemocyanin-conjugated
NH2-VMTRPIKGPRDIQLDLEMITVN-COOH, corresponding to mur-
ine fibulin-5 amino acids 405–426. For immunocytochemical stud-
ies fibulin-5 was stained using purified antibodies to fibulin-5
already described (Yanagisawa et al, 2002).
Dermal ﬁbroblast preparation Primary dermal fibroblast cultures
were prepared from newborn mice, 2–3 d after birth. Mice were
euthanized, washed in 70% ethanol, tails and limbs amputated and
skin dissected. Dissected skin was floated on 0.25% trypsin in
HBSS, epidermal side up, overnight at 41C. The next day the der-
mal layer was peeled from the epidermis and digested in 0.4 mg
per mL collagenase (Worthington, Lakewood, New Jersey CLS2) in
Hank’s balanced salt solution for 4 h at room temperature. The
resulting fibroblasts were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum (FBS) and
penicillin/streptomycin, generally reaching confluence in a 90 mm
tissue culture dish within in 1–2 d.
Immunohistochemistry/immunoﬂuorescence For immunohisto-
chemistry, tissues were fixed overnight to several days in buffered
4% paraformaldehyde and then processed through graded ethanols
and embedded in paraffin. Sections were cut, mounted on un-
coated slides, and hydrated by passage through xylene and grad-
ed ethanols. For immunocytochemistry, cells were passaged at
50% confluence ( 30,000 cells per well of an eight-well slide)
and fixed in either methanol (fibulin-2) or 4% paraformaldehyde
(fibulin-5). Sections or cultured cells preparations were washed in
TBS (50 mM Tris pH 8.0, 150 mM NaCl) and blocked 30 min in
TBSþ 3% BSA.
Staining with rabbit antisera to fibulin-2, fiblin-5, fibrilllin-1, and
elastin was controlled by using the same dilution of normal rabbit
sera on parallel cell culture preparations or serial tissue sections.
Primary antibodies were diluted (1:1000) with 3% BSA in TBS.
Incubations were carried out for 3 h to overnight in a humidified
chamber, slides washed with three changes of TBS over 30 min,
and secondary antibody added. For immunofluorescence, rhoda-
mine-conjugated donkey anti-rabbit IgG (Jackson Immunochem-
icals, West Grove, Pennsylvania) was used at a 1:200 dilution with
3% BSA in TBS. For immunohistochemistry anti-rabbit/anti-mouse
alkaline phosphatase labeled polymer was used without dilution
(Envision, Daykocytomation Carpenteria, California). Slides were
incubated with secondary detection reagents for 45 min and
washed with TBS for 30 min. In immunofluorescent studies nuclei
were counterstained by treating slides for 5 min with 100 ng per mL
Hoechst 33342 (Molecular Probes, Eugene, Oregon) in TBS for
5 min followed by further washes in TBS. Stained nuclei were de-
tected using UV filters. Immunofluorescent staining was detected
using filter sets for rhodamine as described (Sarkissian and La-
fyatis, 1998). Immunohistochemical staining was detected using Fast
red, developing 15 min. Tissues were counterstained 15–30 s in
Mayer’s Hematoxylin (DAKO) followed by a 1 min incubation in
0.08% NH4OH. After additional washes in distilled water, sections
were mounted and viewed under an Olympus BH2 microscope
(Olympus, Melville, New York).
Harts resorcin–fuchsin elastin stain Stain was prepared by mix-
ing 5 mL resorcin–fuchsin stock solution (Elastin Products, No.
IN342, Owensville, Missouri), 50 mL 70% ethanol, and 1 mL con-
centrated HCl. Hydrated tissue sections were emersed overnight
and washed the next day in water for 30 min.
Northern blot RNAs from skin tissues of mice were prepared by
mincing and disrupting 100 mg of skin directly into 3 mL of Tri
Reagent (MRC, Cincinnati, Ohio) using a Polytron homogenizer
(Brinkman, Westbury, New York). After centrifugation, the aqueous
phase was precipitated and the resulting pellet purified over
RNeasy columns according to the manufacture#s protocol (Qia-
gen, Valencia, California). The RNAs were analyzed on a formal-
dehyde gel and blotted onto nylon membrane. cDNAs of fibulin-2
(from clone #MGC-6112, ATTC) and fibulin-5 (Schiemann et al,
2002) and fibrillin-1 (Kissin et al, 2002) labeled with 32P dCTP using
random primed labeling. Probes were hybridized to membranes
and washed as described (Lemaire et al, 2002). Signals were de-
tected using a Cyclone phosphorimager (Hewlett-Packard, Palo
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Alto, California) and quantified using provided Optiquant software
(Perkin Elmer, Boston, Massachusetts).
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